Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 16:28:24
284,95 DKK
Kurs
Kurs
2,33%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 25.09.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.11.2026 0 Monate | 12.11.2026 | 0 Monate | 284,95 305 | 284,95 | 305 | 7,036322 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 240 | 284,95 | 240 | 15,774697 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 240 | 284,95 | 240 | 15,774697 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.11.2026 0 Monate | 05.11.2026 | 0 Monate | 284,95 223 | 284,95 | 223 | 21,740656 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JEFFERIES | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JPMORGAN | ||
| Novo Nordisk AS | 04.11.2026 12 Monate | 04.11.2026 | 12 Monate | 284,95 304 | 284,95 | 304 | 6,685383 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 284,95 312 | 284,95 | 312 | 9,492893 | UBS | ||
| Novo Nordisk AS | 28.10.2026 0 Monate | 28.10.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JPMORGAN | ||
| Novo Nordisk AS | 14.10.2026 0 Monate | 14.10.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 225 | 284,95 | 225 | 21,038779 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.10.2026 0 Monate | 05.10.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 284,95 245 | 284,95 | 245 | 14,020004 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 245 | 284,95 | 245 | 14,020004 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 22.09.2026 12 Monate | 22.09.2026 | 12 Monate | 284,95 305 | 284,95 | 305 | 7,036322 | BERENBERG | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 284,95 285 | 284,95 | 285 | 0,017547 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JEFFERIES | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 284,95 260 | 284,95 | 260 | 8,755922 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS | ||
| Novo Nordisk AS | 16.09.2026 0 Monate | 16.09.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 284,95 265 | 284,95 | 265 | 7,001228 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 284,95 300 | 284,95 | 300 | 5,281628 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 284,95 265 | 284,95 | 265 | 7,001228 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 265 | 284,95 | 265 | 7,001228 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 284,95 305 | 284,95 | 305 | 7,036322 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 284,95 | 284,95 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 284,95 285 | 284,95 | 285 | 0,017547 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 284,95 200 | 284,95 | 200 | 29,812248 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 284,95 310 | 284,95 | 310 | 8,791016 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 284,95 285 | 284,95 | 285 | 0,017547 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 284,95 285 | 284,95 | 285 | 0,017547 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 284,95 325 | 284,95 | 325 | 14,055097 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 284,95 305 | 284,95 | 305 | 7,036322 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 284,95 300 | 284,95 | 300 | 5,281628 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 284,95 175 | 284,95 | 175 | 38,585717 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 290 | 284,95 | 290 | 1,772241 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 284,95 | 284,95 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 284,95 300 | 284,95 | 300 | 5,281628 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 284,95 263 | 284,95 | 263 | 7,703106 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 284,95 175 | 284,95 | 175 | 38,585717 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 284,95 300 | 284,95 | 300 | 5,281628 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 284,95 263 | 284,95 | 263 | 7,703106 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 284,95 300 | 284,95 | 300 | 5,281628 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 284,95 260 | 284,95 | 260 | 8,755922 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 284,95 400 | 284,95 | 400 | 40,375504 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 284,95 400 | 284,95 | 400 | 40,375504 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 284,95 332 | 284,95 | 332 | 16,511669 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 284,95 340 | 284,95 | 340 | 19,319179 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 284,95 350 | 284,95 | 350 | 22,828566 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 284,95 340 | 284,95 | 340 | 19,319179 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 284,95 275 | 284,95 | 275 | 3,491841 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 284,95 250 | 284,95 | 250 | 12,26531 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 284,95 270 | 284,95 | 270 | 5,246534 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 284,95 340 | 284,95 | 340 | 19,319179 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 284,95 340 | 284,95 | 340 | 19,319179 | BARCLAYS |
News
Aktuell
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M